Table 4.
Premature menopause, Time from menopause and risk of Fibrosis: subgroup analysis in patients with borderline NASH or NASH
Univariate COR(95%CI), p-value |
Model 1 COR(95%CI), p-value |
Model 2 COR(95%CI), p-value |
|
---|---|---|---|
Premature menopause | |||
No | - | - | - |
Yes | 1.2 [0.9–1.8], p=0.27 | 1.6 [1.1–2.4], p=0.02 | 1.4 [0.9–2.1], p=0.11 |
Time from menopause, for 5 years | 1.2 [1.1–1.4], p<0.0001 | 1.2 [1.0–1.3], p=0.01 | 1.1 [1.0–1.3], p=0.05 |
Model 1: Adjusted for age at enrollment, race, waist circumference/BMI, current smoking/alcohol use, hypertension, diabetes/IFG, HOMA-IR, and HRT.
Model 2: Adjusted for the above covariates, hepatocyte ballooning grades, and portal inflammation grades.